RP 001 - Vacino Biotech
Alternative Names: RP-001 - Vacino Biotech; VACINO-ADmirLatest Information Update: 15 Dec 2022
At a glance
- Originator Vacino Biotech
- Class Antidementias; Nucleic acids
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Alzheimer's disease
Most Recent Events
- 15 Dec 2022 Early research in Alzheimer's disease in China (unspecified route) before December 2022 (Vacino Biotech pipeline, December 2022)